文献速递冠心病

冠状动脉循环功能的综合无创生理评估及其对稳定性冠心病患者心血管死亡率的影响

Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease.
PubMed 文献 · Circulation · 2017-09-01

本研究在4029例已知或疑似稳定性冠心病患者中,通过静息/负荷心肌灌注PET量化最大心肌血流量(MBF)和冠状动脉血流储备(CFR),发现CFR对心血管死亡的预测能力强于最大MBF,整合CFR与最大MBF的一致或不一致受损可识别不同预后表型。

要点

  • CFR是比最大MBF更强的心血管死亡预测因子。
  • CFR与最大MBF一致受损者心血管死亡率最高,一致保留者最低。
  • CFR受损但最大MBF保留者以女性为主,预后居中。

核心结论

  • CFR对心血管死亡的预测能力强于最大MBF,整合两者可识别独特的预后表型。

主要发现

  • 中位随访5.6年,发生392例(9.7%)心血管死亡。
  • 校正最大MBF和临床协变量后,CFR每降低1单位的心血管死亡调整风险比为1.79(95%CI 1.38-2.31,P<0.001)。
  • 校正CFR和临床协变量后,最大MBF每降低1单位的心血管死亡调整风险比为1.03(95%CI 0.84-1.27,P=0.8)。
  • 单变量分析中,CFR与最大MBF一致受损者心血管死亡率为每年3.3%(95%CI 2.9-3.7),CFR受损但最大MBF保留者为每年1.7%(95%CI 1.3-2.1),CFR保留但最大MBF受损者为每年0.9%(95%CI 0.6-1.6),一致保留者为每年0.4%(95%CI 0.3-0.6)。
  • CFR受损但最大MBF保留者中女性占70%。

关键数值与推荐

  • 最大MBF<1.8 mL·g-1·min-1和CFR<2定义为受损。

临床怎么用

  • 在稳定性冠心病患者中,应重视CFR评估以进行风险分层。
  • 整合CFR和最大MBF的一致或不一致受损模式有助于识别高危患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is suggested that the integration of maximal myocardial blood flow (MBF) and coronary flow reserve (CFR), termed coronary flow capacity, allows for comprehensive evaluation of patients with known or suspected stable coronary artery disease. Because management decisions are predicated on clinical risk, we sought to determine the independent and integrated value of maximal MBF and CFR for predicting cardiovascular death. METHODS: MBF and CFR were quantified in 4029 consecutive patients (median age 66 years, 50.5% women) referred for rest/stress myocardial perfusion positron emission tomography scans from January 2006 to December 2013. The primary outcome was cardiovascular mortality. Maximal MBF <1.8 mL·g-1·min-1 and CFR<2 were considered impaired. Four patient groups were identified based on the concordant or discordant impairment of maximal MBF or CFR. Association of maximal MBF and CFR with cardiovascular death was assessed using Cox and Poisson regression analyses. RESULTS: A total of 392 (9.7%) cardiovascular deaths occurred over a median follow-up of 5.6 years. CFR was a stronger predictor of cardiovascular mortality than maximal MBF beyond traditional cardiovascular risk factors, left ventricular ejection fraction, myocardial scar and ischemia, rate-pressure product, type of radiotracer or stress agent used, and revascularization after scan (adjusted hazard ratio, 1.79; 95% confidence interval [CI], 1.38-2.31; P<0.001 per unit decrease in CFR after adjustment for maximal MBF and clinical covariates; and adjusted hazard ratio, 1.03; 95% CI, 0.84-1.27; P=0.8 per unit decrease in maximal MBF after adjustment for CFR and clinical covariates). In univariable analyses, patients with concordant impairment of CFR and maximal MBF had high cardiovascular mortality of 3.3% (95% CI, 2.9-3.7) per year. Patients with impaired CFR but preserved maximal MBF had an intermediate cardiovascular mortality of 1.7% (95% CI, 1.3-2.1) per year. These patients were predominantly women (70%). Patients with preserved CFR but impaired maximal MBF had low cardiovascular mortality of 0.9% (95% CI, 0.6-1.6) per year. Patients with concordantly preserved CFR and maximal MBF had the lowest cardiovascular mortality of 0.4% (95 CI, 0.3-0.6) per year. In multivariable analysis, the cardiovascular mortality risk gradient across the 4 concordant or discordant categories was independently driven by impaired CFR irrespective of impairment in maximal MBF. CONCLUSIONS: CFR is a stronger predictor of cardiovascular mortality than maximal MBF. Concordant and discordant categories based on integrating CFR and maximal MBF identify unique prognostic phenotypes of patients with known or suspected coronary artery disease.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Gupta A, Taqueti VR, van de Hoef TP, et al. Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease. Circulation. 2017. PMID: 28864442. doi:10.1161/CIRCULATIONAHA.117.029992

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。